{"meta":{"page":1,"per_page":50,"max_per_page":100,"total":23,"total_is_capped":false,"direct_labels_cover":0,"predictions_cover":23,"direct_label_status":"direct model label, unvalidated","prediction_status":"machine_predicted_unvalidated (Codex and Gemma teacher distillation)","score_status":"score_only:v0-immature-baseline (scores rank; they never assert a category)","snapshot":{"source":"OpenAlex, pinned release, all 482 partitions","release":"2026-06-24","frame_built":"2026-07-12","author_layer_release":"2026-06-26"},"query_hash":"53a01e2d7de3","filters":{"venue":"Canadian oncology today."}},"results":[{"id":"W4409361713","doi":"10.58931/cot.2025.2132","title":"Current Approaches and Future Directions for the Treatment of Solid Tumour Brain Metastases","year":2025,"lang":"en","type":"article","venue":"Canadian oncology today.","topic":"Brain Metastases and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Sunnybrook Health Science Centre; University of Toronto","funders":"National Cancer Institute; NRG Oncology; Breast Cancer Alliance","keywords":"Current (fluid); Medicine; Intensive care medicine; Oncology; Geology; Oceanography","authors":[{"name":"Jie Wei Zhu","is_ca":true},{"name":"Ines B. Menjak","is_ca":true},{"name":"Arjun Sahgal","is_ca":true},{"name":"Katarzyna J. Jerzak","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.04357760434610908,"gpt":0.3341974779735046,"spread":0.2906198736273956,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001554999,0.0001413011,0.0003611555,0.0001713221,0.0002102498,0.000006380732,0.00004651551,0.00007126163,0.0000553586],"category_scores_gemma":[0.00004818833,0.0000871778,0.0001359585,0.0001612503,0.0001448696,0.00001576912,0.000007016828,0.00006488216,0.000001527055],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0004630923,"about_ca_system_score_gemma":0.00109263,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.005651543,"about_ca_topic_score_gemma":0.09266431,"domain_scores_codex":[0.9992486,0.00006987028,0.0001795574,0.0002120254,0.00004429795,0.0002456644],"domain_scores_gemma":[0.9990154,0.0004642842,0.00005146178,0.0002115401,0.00004868789,0.0002086158],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0001051072,0.0005342364,0.001183891,0.00006545964,0.0008631203,0.00002476962,0.0006349349,0.000003970964,0.00002255508,0.009038579,0.02968182,0.9578416],"study_design_scores_gemma":[0.001929717,0.001148531,0.012767,0.00002093346,0.0009530194,0.00003508036,0.001000022,0.0001042385,0.0002839917,0.0002374126,0.9814601,0.00005995823],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"commentary","genre_gemma":"empirical","genre_scores_codex":[0.1562651,0.3465623,0.001011683,0.4734704,0.003872664,0.007701289,0.004324998,0.00008742984,0.006704167],"genre_scores_gemma":[0.9590715,0.02225643,0.004570728,0.004674521,0.001576809,0.002045634,0.0005610363,0.00005873102,0.005184571],"genre_candidate":"empirical","genre_consensus":null,"teacher_disagreement_score":0.9577816,"threshold_uncertainty_score":0.9238922,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4403604899","doi":"10.58931/cot.2024.1222","title":"From Intractable to Treatable: Milestones and Horizons in the Management of HER2+ Breast Cancer","year":2024,"lang":"en","type":"article","venue":"Canadian oncology today.","topic":"HER2/EGFR in Cancer Research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Breast cancer; Medicine; New horizons; Cancer; General surgery; Internal medicine; Engineering","authors":[{"name":"Meredith Li","is_ca":true},{"name":"David W. Cescon","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.02702545990048791,"gpt":0.3752658411589677,"spread":0.3482403812584798,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0003508559,0.0001153425,0.0002636514,0.0002994816,0.00004694483,0.00002539959,0.0001762132,0.0001200608,0.001282819],"category_scores_gemma":[0.00001362462,0.00008796586,0.00002630317,0.0005880351,0.0001228056,0.00004541713,0.00003990989,0.0002991034,0.00004805498],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001235421,"about_ca_system_score_gemma":0.001848767,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_topic_score_codex":0.5588971,"about_ca_topic_score_gemma":0.6270247,"domain_scores_codex":[0.9988142,0.00007454814,0.0001934422,0.0003087377,0.000171854,0.0004371994],"domain_scores_gemma":[0.9991122,0.0001456359,0.00001494212,0.0002945751,0.00004122237,0.0003914254],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.000176816,0.0001191656,0.02755822,0.0005611852,0.0003827695,0.006050378,0.004917508,0.00001692334,0.0006117059,0.002112479,0.2517593,0.7057335],"study_design_scores_gemma":[0.0006143341,0.0003248989,0.194177,0.0008671485,0.0001440687,0.0001828443,0.002877842,0.00009093031,0.0001205043,0.0002555275,0.8002143,0.000130618],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.8221537,0.009070018,0.000008639941,0.1286988,0.0006870753,0.001180245,0.001100103,0.0000284633,0.03707288],"genre_scores_gemma":[0.9927078,0.001495712,0.0003824842,0.001973671,0.0003274873,0.0003184766,0.00002969504,0.00002781641,0.002736877],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.7056029,"threshold_uncertainty_score":0.9996302,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4415935375","doi":"10.58931/cot.2025.2341","title":"First-line Treatment Selection for Advanced Unresectable Biliary Tract Cancer","year":2025,"lang":"","type":"article","venue":"Canadian oncology today.","topic":"Cholangiocarcinoma and Gallbladder Cancer Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Ottawa Hospital; University of Ottawa","funders":"","keywords":"Biliary tract cancer; Biliary tract; Gallbladder cancer; Gallbladder; Cancer; Selection (genetic algorithm)","authors":[{"name":"Arwa Ahmed Abdelrahim","is_ca":true},{"name":"Rachel Goodwin","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.0307555360118916,"gpt":0.3467443021864418,"spread":0.3159887661745502,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0002537156,0.0006139477,0.00126413,0.0007938402,0.00105236,0.00003875036,0.0002149517,0.0006548069,0.001347766],"category_scores_gemma":[0.0002707211,0.0005977092,0.0004072336,0.0009536518,0.0002546053,0.0001434357,0.00003589414,0.0004115074,0.00003961613],"about_ca_system_candidate":true,"about_ca_system_consensus":true,"about_ca_system_score_codex":0.01729657,"about_ca_system_score_gemma":0.01737125,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_topic_score_codex":0.3121234,"about_ca_topic_score_gemma":0.951934,"domain_scores_codex":[0.9964832,0.000102058,0.0006841696,0.001033058,0.0001456092,0.001551879],"domain_scores_gemma":[0.9974039,0.0006145604,0.0001838302,0.0004631373,0.0004574616,0.0008771556],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.002825618,0.001200947,0.2118101,0.000946662,0.003415321,0.0002743007,0.002647894,0.001155869,0.000666188,0.0007617734,0.216903,0.5573924],"study_design_scores_gemma":[0.01099431,0.005212529,0.05212387,0.0005345034,0.001964511,0.00003465613,0.0007323406,0.001607835,0.001329749,0.0002613631,0.9247345,0.0004698831],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"empirical","genre_scores_codex":[0.3095118,0.3113886,0.0007992597,0.2405775,0.02260074,0.01316329,0.002930904,0.0002704435,0.09875748],"genre_scores_gemma":[0.9151184,0.01621613,0.0002737963,0.005792848,0.001553974,0.002847958,0.0001371719,0.00007285213,0.05798689],"genre_candidate":"empirical","genre_consensus":null,"teacher_disagreement_score":0.7078315,"threshold_uncertainty_score":0.9996474,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4403961654","doi":"10.58931/cot.2024.1326","title":"Prostate-specific Membrane Antigen (PSMA): A Diagnostic and Therapeutic Target in Advanced Prostate Cancer","year":2024,"lang":"en","type":"article","venue":"Canadian oncology today.","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Health Sciences Centre; University of Toronto; Sunnybrook Health Science Centre","funders":"","keywords":"Glutamate carboxypeptidase II; Prostate cancer; Prostate-specific antigen; Medicine; Prostate; Antigen; Cancer; Cancer research; Oncology; Internal medicine; Immunology","authors":[{"name":"Urban Emmenegger","is_ca":true},{"name":"Rubens Copia Sperandio","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.02155911978043243,"gpt":0.3279031155264364,"spread":0.3063439957460039,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002684602,0.0002574225,0.000449843,0.0005821615,0.0001212373,0.00005572569,0.00009814416,0.0002025915,0.0007093151],"category_scores_gemma":[0.00006098003,0.0002099859,0.00005631184,0.0006095347,0.0002988735,0.0001096257,0.00002933975,0.0004997146,0.00008352724],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001804027,"about_ca_system_score_gemma":0.003864505,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_topic_score_codex":0.01405016,"about_ca_topic_score_gemma":0.08814377,"domain_scores_codex":[0.9979551,0.00009065704,0.0002910903,0.0005956121,0.0001744626,0.0008930718],"domain_scores_gemma":[0.998668,0.0003045203,0.0000310312,0.0002295346,0.00008111794,0.0006858559],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.001390104,0.0002663556,0.3813276,0.0009856707,0.0005090567,0.02155863,0.01038156,0.0001040916,0.01148415,0.001072768,0.01303338,0.5578867],"study_design_scores_gemma":[0.00400636,0.001064402,0.1123588,0.0007717273,0.00006726721,0.0002025344,0.0006391653,0.0004202164,0.002319104,0.0006998488,0.8770745,0.0003759835],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.8268143,0.1390596,0.000001950715,0.0268536,0.0006356152,0.002061756,0.0002056713,0.00008534348,0.004282226],"genre_scores_gemma":[0.9554427,0.03641665,0.000145471,0.001158623,0.0001508276,0.0007451629,0.0001099451,0.00006436496,0.00576627],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.8640411,"threshold_uncertainty_score":0.9925154,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4413382302","doi":"10.58931/cot.2025.2236","title":"Perioperative Treatment Strategies for Lung Cancer in 2025: A Paradigm Shift","year":2025,"lang":"en","type":"article","venue":"Canadian oncology today.","topic":"Lung Cancer Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Quebec - Clinical Research Organization in Cancer; Centre Hospitalier de l’Université de Montréal","funders":"","keywords":"Perioperative; Paradigm shift; Intensive care medicine; Lung cancer; Cancer; Medicine; Oncology; Internal medicine; Anesthesia; Philosophy; Epistemology","authors":[{"name":"Ramy Samaha","is_ca":true},{"name":"Jonathan Spicer","is_ca":true},{"name":"Normand Blais","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.02011802074576969,"gpt":0.3727308848975044,"spread":0.3526128641517347,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00006499598,0.0001915534,0.0004563965,0.0002716173,0.0001177077,0.00002747475,0.00006172222,0.0001710054,0.000479173],"category_scores_gemma":[0.00001351126,0.0001576437,0.00009656342,0.000205852,0.00007757299,0.00005943261,0.000007249814,0.0000953631,0.000005998289],"about_ca_system_candidate":true,"about_ca_system_consensus":true,"about_ca_system_score_codex":0.01047535,"about_ca_system_score_gemma":0.01321598,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_topic_score_codex":0.1968808,"about_ca_topic_score_gemma":0.9208688,"domain_scores_codex":[0.9989035,0.00003805254,0.0002135947,0.0003501663,0.00004631609,0.0004484453],"domain_scores_gemma":[0.9993421,0.0001218531,0.00003291546,0.0001971604,0.000033957,0.0002719717],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0009893634,0.001215773,0.59297,0.0004243992,0.002359078,0.001528692,0.01195456,0.0008107835,0.00005851009,0.2254364,0.05689791,0.1053545],"study_design_scores_gemma":[0.01285062,0.002204868,0.2281076,0.0005659835,0.000755136,0.00001126874,0.001540404,0.001146544,0.0002677263,0.001556249,0.7506744,0.0003191936],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.5197654,0.03350885,0.0001936362,0.2948243,0.002225019,0.007636844,0.0008309814,0.00008765676,0.1409273],"genre_scores_gemma":[0.987597,0.000927745,0.0001354016,0.003643176,0.0001239934,0.003748017,0.0000533511,0.0000156243,0.00375563],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.723988,"threshold_uncertainty_score":0.9933233,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4415934922","doi":"10.58931/cot.2025.2342","title":"Original Research: Biomarker Testing in a Canadian Centre for Patients with Non‑small Cell Lung Cancer: Assessing Residual Risks","year":2025,"lang":"","type":"article","venue":"Canadian oncology today.","topic":"Lung Cancer Treatments and Mutations","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"University of Manitoba; Manitoba Health; Lunenfeld-Tanenbaum Research Institute; Occupational Cancer Research Centre; Public Health Ontario; University of Toronto; Toronto Public Health","funders":"","keywords":"ROS1; Erlotinib; Guideline; Biomarker; Lung cancer; Crizotinib; Epidermal growth factor receptor; Genetic testing; Cancer","authors":[{"name":"Yunting Liu","is_ca":true},{"name":"Steven H. Shen","is_ca":true},{"name":"Janet I. Malowany","is_ca":true},{"name":"Shaheed W. Hakim","is_ca":true},{"name":"Zared Aziz","is_ca":true},{"name":"David N. Parente","is_ca":true},{"name":"Victoria Cheung","is_ca":true},{"name":"Suneil Khanna","is_ca":true},{"name":"Yoo‐Joung Ko","is_ca":true},{"name":"Wondwossen Kidanewold","is_ca":true},{"name":"Michael A. Ko","is_ca":true},{"name":"Kelsie L. Thu","is_ca":true},{"name":"Ju‐Yoon Yoon","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.07447973931669052,"gpt":0.4308980292734839,"spread":0.3564182899567934,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow","sts"],"consensus_categories":[],"category_scores_codex":[0.001101589,0.0005311355,0.0008231639,0.002950195,0.0014741,0.0001968289,0.0003838491,0.0006952098,0.000435137],"category_scores_gemma":[0.0007980825,0.0005223851,0.00008867,0.002540305,0.0004184423,0.0002200555,0.00005060642,0.001048302,0.00001963192],"about_ca_system_candidate":true,"about_ca_system_consensus":true,"about_ca_system_score_codex":0.03653911,"about_ca_system_score_gemma":0.1627553,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_topic_score_codex":0.9907039,"about_ca_topic_score_gemma":0.9991512,"domain_scores_codex":[0.9940246,0.0004125918,0.0007416886,0.001143596,0.0003312804,0.003346225],"domain_scores_gemma":[0.9936405,0.001266877,0.0002230524,0.0005492648,0.001609071,0.002711264],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.0002419782,0.0003321505,0.9086581,0.0004933279,0.0004558795,0.0008261606,0.001722967,0.0001055749,0.00001346217,0.0001404084,0.04385665,0.04315336],"study_design_scores_gemma":[0.01295057,0.0009334378,0.6797189,0.003219258,0.001375401,0.000005918501,0.002529382,0.00280167,0.00003213239,0.00005704521,0.2958452,0.0005311425],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.8508728,0.004305928,0.00003067566,0.02331348,0.002280752,0.007182126,0.001948968,0.00002960823,0.1100357],"genre_scores_gemma":[0.984668,0.0001094712,0.00212483,0.001767249,0.0003319842,0.0008010332,0.0004423182,0.00009674557,0.009658396],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.2519885,"threshold_uncertainty_score":0.9998258,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4403961830","doi":"10.58931/cot.2024.1329","title":"Antibody-drug Conjugates in The Management of Advanced Urothelial Carcinoma","year":2024,"lang":"en","type":"article","venue":"Canadian oncology today.","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"McMaster University; Juravinski Cancer Centre","funders":"","keywords":"Urothelial carcinoma; Antibody; Drug; Antibody-drug conjugate; Medicine; Conjugate; Carcinoma; Cancer research; Internal medicine; Pharmacology; Immunology; Monoclonal antibody; Cancer; Bladder cancer","authors":[{"name":"Pooya Dibajnia","is_ca":true},{"name":"Aly‐Khan A. Lalani","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.01436082432163959,"gpt":0.3159683875812592,"spread":0.3016075632596196,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001755053,0.0001280965,0.0002480732,0.0001999022,0.00004250894,0.00001081109,0.0001411333,0.00007626489,0.0003333179],"category_scores_gemma":[0.000005337574,0.00009155638,0.00007305276,0.0002804104,0.0001097298,0.00004135867,0.00001380482,0.0001780281,0.00007539504],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0004485589,"about_ca_system_score_gemma":0.001031692,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_topic_score_codex":0.02742382,"about_ca_topic_score_gemma":0.05376488,"domain_scores_codex":[0.9990606,0.00005607828,0.0002101117,0.0002367199,0.0001197384,0.0003167118],"domain_scores_gemma":[0.9994892,0.00005898025,0.00002228918,0.0002446866,0.00002602657,0.0001588424],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.001687536,0.001108655,0.1919471,0.003772584,0.002453358,0.06222238,0.03145682,0.00006524666,0.009273951,0.06290098,0.05439006,0.5787213],"study_design_scores_gemma":[0.004863058,0.001158577,0.2205006,0.0006899194,0.0005289402,0.0003495971,0.004367403,0.0001012846,0.001460969,0.001180474,0.764527,0.0002721531],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.7811306,0.007284692,0.000009533332,0.01323504,0.000918451,0.001217669,0.0001320157,0.00003680107,0.1960353],"genre_scores_gemma":[0.995291,0.0003144582,0.0001872211,0.002020817,0.0001079319,0.00008259426,0.00005171503,0.00001963436,0.001924631],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.710137,"threshold_uncertainty_score":0.9790527,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4413417222","doi":"10.58931/cot.2025.2235","title":"Antibody-Drug Conjugates in Breast Cancer: Current Landscape and Future Targets","year":2025,"lang":"en","type":"article","venue":"Canadian oncology today.","topic":"HER2/EGFR in Cancer Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"Ottawa Hospital; Mount Sinai Hospital","funders":"University of Toronto; University of Ottawa","keywords":"Antibody-drug conjugate; Breast cancer; Antibody; Drug; Conjugate; Medicine; Cancer; Cancer drugs; Current (fluid); Immunology; Cancer research; Pharmacology; Monoclonal antibody; Internal medicine; Engineering","authors":[{"name":"Jennifer Leigh","is_ca":true},{"name":"Arif Awan","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.01183949079664731,"gpt":0.3703987486551005,"spread":0.3585592578584532,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0003123723,0.0001666039,0.0004243012,0.0005623053,0.0001009716,0.00001997822,0.000145617,0.0002029123,0.001244961],"category_scores_gemma":[0.00003833567,0.0001564009,0.00003837007,0.0004743966,0.0001845416,0.00004686491,0.0000480125,0.0006482152,0.00003039915],"about_ca_system_candidate":true,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00130706,"about_ca_system_score_gemma":0.006786799,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_topic_score_codex":0.07050847,"about_ca_topic_score_gemma":0.4718176,"domain_scores_codex":[0.998491,0.0001006155,0.0002391592,0.0003842956,0.0001294365,0.0006554256],"domain_scores_gemma":[0.9988803,0.00008301622,0.00003424411,0.0002436153,0.0001232638,0.0006356185],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00008662782,0.00005088924,0.7264696,0.000223336,0.00004210008,0.0004187473,0.0004086522,0.000001412855,0.0002180633,0.0006271683,0.1281613,0.1432921],"study_design_scores_gemma":[0.001199237,0.00004141007,0.3433913,0.000232049,0.0000231893,0.00006033386,0.0002981345,0.00009733166,0.00003810783,0.00008959591,0.6544292,0.0001000695],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.4461084,0.1099959,0.000003972962,0.3771551,0.003826805,0.00144666,0.0005981013,0.00007643121,0.06078863],"genre_scores_gemma":[0.9664779,0.02309321,0.00007013705,0.006922191,0.001152223,0.0001676157,0.0001575738,0.00003394463,0.001925154],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.5262679,"threshold_uncertainty_score":0.9996681,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4413382855","doi":"10.58931/cot.2025.2239","title":"Small-Cell Lung Cancer: Integration of Radiation and Immunotherapy for All Stages","year":2025,"lang":"en","type":"article","venue":"Canadian oncology today.","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Hôpital Charles-Le Moyne","funders":"","keywords":"Immunotherapy; Lung cancer; Cancer; Medicine; Radiation therapy; Oncology; Cancer research; Internal medicine","authors":[{"name":"Nathalie Daaboul","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.02511551505060303,"gpt":0.3782479123245323,"spread":0.3531323972739293,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002101697,0.00008711909,0.0002601538,0.000271972,0.00007415147,0.000007007241,0.00006078088,0.0001119618,0.00005266319],"category_scores_gemma":[0.0001187381,0.0000799293,0.00003831639,0.0001319384,0.0001024024,0.00003152994,0.00001160318,0.0001144666,4.548855e-7],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001424661,"about_ca_system_score_gemma":0.002709858,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_topic_score_codex":0.06419909,"about_ca_topic_score_gemma":0.2699619,"domain_scores_codex":[0.9993266,0.00003850845,0.0001711088,0.0001665233,0.00005402365,0.0002432183],"domain_scores_gemma":[0.9993641,0.0001691283,0.0000572077,0.0001302622,0.000151863,0.0001274532],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0006732643,0.00008622734,0.1573101,0.0007871922,0.0008531539,0.00001892923,0.003288758,0.0000127278,0.0326205,0.002275824,0.1882447,0.6138286],"study_design_scores_gemma":[0.009390092,0.001529141,0.1799705,0.000429374,0.0004279586,0.000005558492,0.001077204,0.001146028,0.03614343,0.0004577826,0.769169,0.000253932],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.8067602,0.08449829,0.001598422,0.07698238,0.001032477,0.00446659,0.0003403855,0.00005405218,0.02426722],"genre_scores_gemma":[0.9724309,0.01168022,0.0008432069,0.004717512,0.0001372753,0.0006216622,0.00007570838,0.00002181233,0.009471661],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.6135747,"threshold_uncertainty_score":0.9420325,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4403604639","doi":"10.58931/cot.2024.1223","title":"Survivorship Issues in Testicular Cancer","year":2024,"lang":"en","type":"article","venue":"Canadian oncology today.","topic":"Testicular diseases and treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"University of British Columbia","funders":"Canadian Institutes of Health Research; National Institutes of Health; Prostate Cancer Foundation; U.S. Department of Defense","keywords":"Survivorship curve; Testicular cancer; Cancer survivorship; Cancer; Medicine; Gerontology; Psychology; Internal medicine","authors":[{"name":"Marco Pisino","is_ca":false},{"name":"Lucia Nappi","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.02406937225909322,"gpt":0.361931690930239,"spread":0.3378623186711458,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00008698563,0.0001204326,0.0002250358,0.0002625117,0.00003399583,0.00001905316,0.00005219453,0.000138154,0.001222064],"category_scores_gemma":[0.0001381136,0.0001051357,0.0000631627,0.0002957291,0.00006054645,0.00003745665,0.000009076506,0.0001620473,0.0003032275],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001248111,"about_ca_system_score_gemma":0.00275657,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_topic_score_codex":0.3899522,"about_ca_topic_score_gemma":0.7029932,"domain_scores_codex":[0.9991196,0.00004101418,0.0001344029,0.0002598689,0.00008135028,0.0003637996],"domain_scores_gemma":[0.9991297,0.00008444952,0.00001196079,0.0001663093,0.00003295333,0.0005745847],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.00003590216,0.0001841877,0.8297837,0.0001905492,0.0002668478,0.03869524,0.0004351703,0.00002646971,0.0001050723,0.003252661,0.02691812,0.1001061],"study_design_scores_gemma":[0.0007230818,0.000248604,0.5258355,0.0003604278,0.0002404542,0.0001779205,0.00007300819,0.0005175914,0.00004188184,0.0006394418,0.4709868,0.0001552186],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.8596139,0.08357126,0.000005861849,0.03643164,0.001140196,0.0005922501,0.000141639,0.0001504672,0.01835281],"genre_scores_gemma":[0.9944487,0.0003024903,0.000152821,0.001564914,0.0001919635,0.00009157548,0.00005186687,0.0000254012,0.003170249],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.4440687,"threshold_uncertainty_score":0.9996909,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4409362115","doi":"10.58931/cot.2025.2134","title":"Advances in Adjuvant Therapy for High-Risk Breast Cancer: A Canadian Clinical Approach","year":2025,"lang":"en","type":"article","venue":"Canadian oncology today.","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"Saskatchewan Cancer Agency; University of Saskatchewan","funders":"","keywords":"Breast cancer; Adjuvant therapy; Medicine; Oncology; Adjuvant; Internal medicine; Cancer","authors":[{"name":"Samitha Andrahennadi","is_ca":true},{"name":"Mita Manna","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.01188623016764734,"gpt":0.3271848254345535,"spread":0.3152985952669062,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003030906,0.000240199,0.0004319665,0.0002497551,0.0002285504,0.00001295104,0.0002871578,0.0004111688,0.00003601165],"category_scores_gemma":[0.0000795497,0.0002311531,0.0001158305,0.0002243147,0.0002260575,0.00000733284,0.00003077364,0.000194829,0.00000421082],"about_ca_system_candidate":true,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0009774492,"about_ca_system_score_gemma":0.006572753,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_topic_score_codex":0.8011976,"about_ca_topic_score_gemma":0.9953799,"domain_scores_codex":[0.9981255,0.0001446005,0.0003446444,0.0006237171,0.00004934125,0.0007122195],"domain_scores_gemma":[0.998946,0.00006996177,0.00009292416,0.0003371967,0.0001207345,0.000433227],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0003568302,0.0001097393,0.4889355,0.00001488655,0.0002122458,0.00001640416,0.00006757712,0.00007508522,0.00002419948,0.000740635,0.02185134,0.4875956],"study_design_scores_gemma":[0.003337235,0.0002437192,0.4255906,0.00002474906,0.00004923372,0.00001202872,0.0001844627,0.00002420118,0.00009256972,0.0004037791,0.5697889,0.0002484734],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.7795313,0.09691118,0.0006079538,0.04917382,0.005839668,0.00449305,0.00964938,0.00006576742,0.05372787],"genre_scores_gemma":[0.9756716,0.0169052,0.0005723852,0.004883686,0.0004058425,0.0008772923,0.0002704283,0.00002676323,0.0003867665],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.5479376,"threshold_uncertainty_score":0.9990591,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4403604925","doi":"10.58931/cot.2024.1220","title":"Current and Emerging Treatment Options for HER2‑Positive Gastroesophageal Cancer","year":2024,"lang":"en","type":"article","venue":"Canadian oncology today.","topic":"Gastric Cancer Management and Outcomes","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Cancer; Current (fluid); Internal medicine; Intensive care medicine; Oncology; Oceanography; Geology","authors":[{"name":"Ronan Andrew McLaughlin","is_ca":true},{"name":"Elena Elimova","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.0256144487643433,"gpt":0.3538786207820933,"spread":0.32826417201775,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00007033913,0.0001321752,0.0002273797,0.0002696833,0.0001206281,0.0000272579,0.00003397791,0.00005569784,0.0003257568],"category_scores_gemma":[0.00001126688,0.0001154825,0.00008301079,0.000143772,0.00005918899,0.00004793423,0.00001141933,0.00009545554,0.00001553695],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001984949,"about_ca_system_score_gemma":0.001173373,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_topic_score_codex":0.01738533,"about_ca_topic_score_gemma":0.1482435,"domain_scores_codex":[0.9991707,0.00001556456,0.0001317967,0.0002661956,0.00005155096,0.0003641582],"domain_scores_gemma":[0.9994098,0.00006523264,0.00001905063,0.00009263548,0.00003712478,0.0003761532],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00005729803,0.00004796347,0.01903239,0.0001446383,0.0003794803,0.0004000718,0.0008512862,0.00001692332,0.00002632137,0.004858551,0.0628183,0.9113668],"study_design_scores_gemma":[0.001190166,0.0007526753,0.04875545,0.0001207841,0.0004934567,0.0000411778,0.0002129865,0.0008021696,0.00002588099,0.0001217505,0.9473836,0.00009983704],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.5025735,0.1821081,0.002581248,0.2615223,0.01376406,0.007590855,0.00209668,0.0005174199,0.02724577],"genre_scores_gemma":[0.9810179,0.004138299,0.0008459105,0.00169932,0.001239479,0.0007725443,0.0001804368,0.00004265726,0.01006345],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.9112669,"threshold_uncertainty_score":0.989158,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4403961907","doi":"10.58931/cot.2024.1325","title":"First-line Treatment Selection for Advanced Hepatocellular Carcinoma","year":2024,"lang":"en","type":"article","venue":"Canadian oncology today.","topic":"Hepatocellular Carcinoma Treatment and Prognosis","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Juravinski Cancer Centre; McMaster University","funders":"","keywords":"Hepatocellular carcinoma; Selection (genetic algorithm); Line (geometry); Oncology; Medicine; Internal medicine; Computer science; Artificial intelligence; Mathematics","authors":[{"name":"Zainab Al Maqrashi","is_ca":true},{"name":"Brandon M. Meyers","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.05903454439788217,"gpt":0.2902703179108537,"spread":0.2312357735129716,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001327168,0.0002763061,0.0004314401,0.0003981058,0.0002264238,0.00003152967,0.00006240043,0.0003080193,0.0005293499],"category_scores_gemma":[0.00003945942,0.0002425517,0.0002819489,0.0003273071,0.00005753095,0.00007522168,0.000007383134,0.0001393119,0.00020816],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.003559769,"about_ca_system_score_gemma":0.002637685,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_topic_score_codex":0.01923839,"about_ca_topic_score_gemma":0.1170079,"domain_scores_codex":[0.9984908,0.00003801042,0.0002675896,0.0005058094,0.0000920013,0.0006058257],"domain_scores_gemma":[0.9987838,0.0001505077,0.00003204675,0.0002190297,0.0001026031,0.0007119587],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0003819469,0.000279154,0.7698607,0.0003350766,0.0006083627,0.002943652,0.0007644983,0.00001378454,0.001484859,0.001867576,0.01173945,0.209721],"study_design_scores_gemma":[0.002529431,0.005106102,0.003221175,0.00008144885,0.000633705,0.0003323262,0.00004811348,0.04515448,0.006265055,0.0002526108,0.9361228,0.0002527922],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9692423,0.007579195,0.0005219028,0.01293834,0.0008732388,0.002366595,0.0001333547,0.0002163754,0.006128672],"genre_scores_gemma":[0.9880986,0.0002426253,0.001433798,0.0005850499,0.0005233784,0.0009376385,0.00039205,0.00006635554,0.007720464],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.9243833,"threshold_uncertainty_score":0.9890971,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4415934991","doi":"10.58931/cot.2025.2343","title":"Current Issues in the Management of Sporadic Non-clear Cell Renal Cell Carcinoma (Non-ccRCC)","year":2025,"lang":"","type":"article","venue":"Canadian oncology today.","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"Queen's University","funders":"","keywords":"Renal cell carcinoma; Kidney cancer; Cell; Clear cell renal cell carcinoma; Carcinoma; Cancer; Clear cell","authors":[{"name":"Mariam Jafri","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.0157094732368646,"gpt":0.2853212277138892,"spread":0.2696117544770246,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.001254038,0.0008550808,0.001584424,0.001604118,0.0002977567,0.00004693237,0.001253349,0.0006243422,0.001072802],"category_scores_gemma":[0.00001839036,0.0007371937,0.0004573851,0.001658158,0.0006564268,0.00009626671,0.0002247494,0.001365393,0.0004471258],"about_ca_system_candidate":true,"about_ca_system_consensus":true,"about_ca_system_score_codex":0.005518809,"about_ca_system_score_gemma":0.006746188,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_topic_score_codex":0.0966721,"about_ca_topic_score_gemma":0.06414606,"domain_scores_codex":[0.994203,0.000557687,0.001565087,0.0012362,0.0006027024,0.001835375],"domain_scores_gemma":[0.9962453,0.0002687942,0.0004731068,0.001813289,0.000209406,0.0009901525],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"not_applicable","study_design_gemma":"observational","study_design_scores_codex":[0.003082216,0.00825204,0.2649895,0.01540112,0.00156599,0.05585797,0.02612599,0.0003077377,0.002629457,0.002533388,0.4652083,0.1540464],"study_design_scores_gemma":[0.01068781,0.004487208,0.5196091,0.001842325,0.00256265,0.00005652643,0.009123395,0.0004686998,0.007863306,0.0002275454,0.4422992,0.0007721991],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.7118882,0.04306992,0.00001783575,0.006813824,0.00204977,0.003132025,0.00008316444,0.00001213427,0.2329331],"genre_scores_gemma":[0.9776758,0.004465277,0.0003197195,0.001475026,0.0003286594,0.0002367926,0.000110109,0.00007028513,0.01531834],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.2657876,"threshold_uncertainty_score":0.9998404,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4403961868","doi":"10.58931/cot.2024.1328","title":"Tailored Approaches and Patient-centered Care: The Current Landscape of Neoadjuvant Therapy in Rectal Cancer","year":2024,"lang":"en","type":"article","venue":"Canadian oncology today.","topic":"Colorectal Cancer Surgical Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"","funders":"","keywords":"Colorectal cancer; Medicine; Current (fluid); Neoadjuvant therapy; Oncology; Cancer; Intensive care medicine; General surgery; Internal medicine; Breast cancer; Engineering","authors":[{"name":"Tharani Krishnan","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.04670660681887358,"gpt":0.3102857813943192,"spread":0.2635791745754456,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00007159258,0.0001438796,0.0003147032,0.0001876875,0.00004074324,0.00001233578,0.000071309,0.00009777031,0.0001866313],"category_scores_gemma":[0.00002293185,0.00009348559,0.00006762493,0.0002935091,0.0001444152,0.00003336425,0.00002400948,0.0002809608,0.00000504406],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0008806856,"about_ca_system_score_gemma":0.00153244,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_topic_score_codex":0.02001438,"about_ca_topic_score_gemma":0.2068434,"domain_scores_codex":[0.9990065,0.00008301104,0.0002178164,0.0002850398,0.0001083611,0.0002992441],"domain_scores_gemma":[0.9994264,0.0001014795,0.00003690554,0.0001576587,0.0000379516,0.00023965],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0003112163,0.00005972734,0.06238026,0.00005712,0.00009412922,0.0002510737,0.004579637,0.000004248757,0.00003378527,0.00007231993,0.001809665,0.9303468],"study_design_scores_gemma":[0.00493452,0.003433445,0.2821186,0.0006340375,0.0001458127,0.0001319897,0.002454573,0.0007977409,0.0005461939,0.0001460234,0.7043486,0.0003084449],"study_design_candidate":"design_other","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.889343,0.09818085,3.667309e-7,0.004802064,0.0007261655,0.0006668453,0.00007585777,0.00001794574,0.006186889],"genre_scores_gemma":[0.9968678,0.002424865,0.00001451902,0.0002947733,0.00007843401,0.0002190201,0.00003122806,0.00001822481,0.00005107251],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.9300384,"threshold_uncertainty_score":0.9865114,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4415935301","doi":"10.58931/cot.2025.2340","title":"Treatment of dMMR Metastatic Colorectal Cancer in 2025","year":2025,"lang":"","type":"article","venue":"Canadian oncology today.","topic":"Genetic factors in colorectal cancer","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Colorectal cancer; Microsatellite instability; DNA mismatch repair; Immune system; Immune checkpoint; Cancer","authors":[{"name":"Renata D’Alpino Peixoto","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.02695592044157716,"gpt":0.3520353368922473,"spread":0.3250794164506701,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0002979534,0.0005947243,0.001857802,0.00167211,0.0001245383,0.00001496705,0.0003567702,0.000677411,0.008948608],"category_scores_gemma":[0.0003672295,0.000603396,0.0002853703,0.001687033,0.0007781226,0.00005092769,0.00005717286,0.0004537868,0.0000861755],"about_ca_system_candidate":true,"about_ca_system_consensus":true,"about_ca_system_score_codex":0.02192351,"about_ca_system_score_gemma":0.04276146,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_topic_score_codex":0.4199803,"about_ca_topic_score_gemma":0.9365275,"domain_scores_codex":[0.9958535,0.0004267086,0.001207606,0.0008633684,0.0002561828,0.001392618],"domain_scores_gemma":[0.9972324,0.0007242142,0.0002788029,0.0005549468,0.0002971816,0.0009124152],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.002356908,0.001816602,0.4151935,0.0007516824,0.002685111,0.002619279,0.006059779,0.0008728232,0.007522303,0.001425005,0.02050845,0.5381886],"study_design_scores_gemma":[0.01956315,0.01492275,0.3792384,0.001497234,0.003151315,0.00008784435,0.003023587,0.002198105,0.02863649,0.0009054076,0.5457383,0.001037412],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.846516,0.05259046,0.000009723589,0.0124082,0.008054653,0.002756753,0.0007390309,0.00001913031,0.07690606],"genre_scores_gemma":[0.9795209,0.006325254,0.0002790448,0.001165073,0.0001817466,0.000694968,0.00003165831,0.00004683669,0.01175454],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.5371512,"threshold_uncertainty_score":0.9996417,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4413417272","doi":"10.58931/cot.2025.2238","title":"Management of Stage I–II Testicular Germ Cell Tumours: Current Treatment Paradigm and Future Perspectives","year":2025,"lang":"en","type":"article","venue":"Canadian oncology today.","topic":"Testicular diseases and treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Germ cell; Stage (stratigraphy); Current (fluid); Medicine; Cancer research; Biology; Engineering; Genetics","authors":[{"name":"Deepro Chowdhury","is_ca":true},{"name":"Rachel Glicksman","is_ca":true},{"name":"Robert J. Hamilton","is_ca":true},{"name":"Di Maria Jiang","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.00975194719520876,"gpt":0.2957172050190887,"spread":0.2859652578238799,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00004355083,0.000203909,0.000365865,0.0002163154,0.0001370006,0.000008260559,0.00005980216,0.00009001942,0.0001538362],"category_scores_gemma":[0.00001017431,0.0001688186,0.0001033476,0.00017755,0.0001292755,0.00002526302,0.00003014258,0.00008699529,0.000007985847],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001266859,"about_ca_system_score_gemma":0.001138762,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.004325262,"about_ca_topic_score_gemma":0.003933969,"domain_scores_codex":[0.9990216,0.00003932671,0.0001865788,0.0003436531,0.00008788832,0.0003209215],"domain_scores_gemma":[0.9990508,0.00003531158,0.00007571659,0.0002970243,0.00005135314,0.0004898104],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"observational","study_design_scores_codex":[0.000336482,0.005482782,0.351609,0.001132283,0.001980169,0.01027552,0.003277089,0.00001987176,0.00006023232,0.06699617,0.005106776,0.5537236],"study_design_scores_gemma":[0.004766028,0.001578705,0.5952982,0.0002051615,0.00180488,0.00003734772,0.003140579,0.00004767737,0.0001150735,0.000331957,0.3924866,0.0001877734],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.8693026,0.09474737,0.00002017642,0.007606658,0.0004366123,0.001345119,0.0002456024,0.00004564447,0.02625025],"genre_scores_gemma":[0.9930077,0.003366634,0.0004941191,0.0001645664,0.00008769093,0.00008635596,0.00006161114,0.00001451092,0.002716766],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.5535358,"threshold_uncertainty_score":0.6884223,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4413417257","doi":"10.58931/cot.2025.2237","title":"Treatment of Neuroendocrine Tumours: Approach of GEP-NETS","year":2025,"lang":"en","type":"article","venue":"Canadian oncology today.","topic":"Neuroendocrine Tumor Research Advances","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Centre Hospitalier de l’Université de Montréal","funders":"","keywords":"Neuroendocrine tumors; Computer science; Internal medicine; Medicine","authors":[{"name":"Nathalie Baudoux","is_ca":true},{"name":"Mustapha Tehfé","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.02555082604383789,"gpt":0.3455222686199967,"spread":0.3199714425761588,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00004142815,0.0001724803,0.0006476993,0.0006638484,0.00004415981,0.000003164324,0.0001741246,0.00001601459,0.0001564063],"category_scores_gemma":[0.0002477485,0.000152244,0.000123006,0.0004577546,0.0003242947,0.00003983414,0.00003146097,0.0001545431,0.00001078385],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0006815952,"about_ca_system_score_gemma":0.00289936,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_topic_score_codex":0.01826679,"about_ca_topic_score_gemma":0.03402377,"domain_scores_codex":[0.9984913,0.0001072095,0.0003706929,0.0003180147,0.0001569004,0.0005559087],"domain_scores_gemma":[0.9986482,0.0001610295,0.00009767368,0.0004615575,0.0001511023,0.0004804698],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"not_applicable","study_design_scores_codex":[0.003209847,0.00680934,0.5109759,0.001904502,0.001299429,0.07128701,0.0005757606,0.0002391108,0.03562127,0.0311782,0.1285124,0.2083873],"study_design_scores_gemma":[0.008008115,0.009268731,0.08249132,0.0001102487,0.000294376,0.004340046,0.0005006262,0.0002465351,0.04955832,0.0004600151,0.8444871,0.0002345971],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.7733224,0.002394419,0.00001478194,0.01682913,0.0003487258,0.001318797,0.00008979457,0.00004146389,0.2056405],"genre_scores_gemma":[0.9889077,0.0003687019,0.000881738,0.0006394663,0.00004410547,0.00007639086,0.00003135698,0.00001970489,0.009030854],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.7159747,"threshold_uncertainty_score":0.9882706,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4403962313","doi":"10.58931/cot.2024.1327","title":"Breast Cancer Survivorship","year":2024,"lang":"en","type":"article","venue":"Canadian oncology today.","topic":"Cancer-related cognitive impairment studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"University of Calgary","funders":"","keywords":"Survivorship curve; Cancer survivorship; Breast cancer; Cancer; Oncology; Medicine; Internal medicine","authors":[{"name":"Nancy Nixon","is_ca":true},{"name":"Sarah Cook","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.02283213416017845,"gpt":0.3269969300789985,"spread":0.3041647959188201,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0001881817,0.0001759701,0.0003100116,0.0003726671,0.0001282179,0.00002241848,0.00007386575,0.0002196143,0.004635707],"category_scores_gemma":[0.0000440636,0.000162451,0.00009870317,0.000440287,0.0001999308,0.00006644835,0.00002261034,0.0004238454,0.0007566665],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.003186919,"about_ca_system_score_gemma":0.004296462,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_topic_score_codex":0.2303521,"about_ca_topic_score_gemma":0.7454941,"domain_scores_codex":[0.9987096,0.00005212715,0.0001865411,0.0003518051,0.000125707,0.0005741992],"domain_scores_gemma":[0.9989009,0.0001318371,0.00002212898,0.0001628531,0.0001346611,0.0006475823],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0001963498,0.0000727568,0.0671903,0.0002411163,0.00103702,0.003917907,0.001224547,0.000005269153,0.0002065541,0.002129729,0.6339172,0.2898613],"study_design_scores_gemma":[0.000814084,0.0002933605,0.1820923,0.000486992,0.0003732744,0.001497339,0.0003372965,0.0001241854,0.00005875442,0.0002180072,0.813446,0.0002583755],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.3518943,0.01844861,0.00003194743,0.2881438,0.008967322,0.001308882,0.001110378,0.0005665471,0.3295282],"genre_scores_gemma":[0.975996,0.0005796601,0.00002545413,0.006213646,0.001033219,0.0001508677,0.00003004313,0.00004470578,0.01592643],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.6241016,"threshold_uncertainty_score":0.9962742,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4403604711","doi":"10.58931/cot.2024.1221","title":"Current Uses and Pitfalls of Liquid Biopsy in NSCLC","year":2024,"lang":"en","type":"article","venue":"Canadian oncology today.","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"Princess Margaret Cancer Centre","funders":"Princess Margaret Cancer Foundation; American Society of Clinical Oncology; International Association for the Study of Lung Cancer","keywords":"Liquid biopsy; Biopsy; Current (fluid); Medicine; Radiology; Medical physics; Internal medicine; Cancer; Physics","authors":[{"name":"Nadia Ghazali","is_ca":true},{"name":"Natasha B. Leighl","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.01120331276767875,"gpt":0.2805186838250549,"spread":0.2693153710573761,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001096374,0.00008805425,0.0001302593,0.0001422976,0.00001948445,0.00001177225,0.0000869514,0.0001425417,0.00003149804],"category_scores_gemma":[0.00007605198,0.00009364125,0.00003319069,0.00009215556,0.0001061645,0.000001910151,0.00004103543,0.00008813168,0.000006990256],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001114305,"about_ca_system_score_gemma":0.001357396,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_topic_score_codex":0.009301424,"about_ca_topic_score_gemma":0.1712963,"domain_scores_codex":[0.9993467,0.00002339381,0.0001557876,0.0002305557,0.00002934514,0.000214174],"domain_scores_gemma":[0.9995979,0.00003538423,0.00002144729,0.0001391602,0.00002777292,0.0001783556],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0005289649,0.0003029203,0.05206301,0.0005707461,0.0003018864,0.000899676,0.001628587,0.0001715348,0.4221415,0.03046228,0.1243314,0.3665975],"study_design_scores_gemma":[0.0003357634,0.0005705769,0.007690805,0.00007735621,0.00001870575,0.00004886686,0.00006065494,0.00004460444,0.007885893,0.0002083117,0.9828786,0.0001798315],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.961873,0.03391086,0.00003307758,0.000901735,0.0006444664,0.0001146009,0.0001362492,0.000004020934,0.002382009],"genre_scores_gemma":[0.9958143,0.003429547,0.0001125303,0.0003176856,0.0001744864,0.00001447123,0.00004578305,0.00001363963,0.00007750961],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.8585472,"threshold_uncertainty_score":0.9972957,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4409361743","doi":"10.58931/cot.2025.2130","title":"The Role of ctDNA in Breast Cancer: Prognosis and Clinical Utility","year":2025,"lang":"en","type":"article","venue":"Canadian oncology today.","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"BC Cancer Agency","funders":"National Cancer Institute","keywords":"Breast cancer; Oncology; Medicine; Internal medicine; Cancer","authors":[{"name":"Mairi Lucas","is_ca":true},{"name":"Stephen Chia","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.007787703013319037,"gpt":0.297753369462649,"spread":0.28996566644933,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003063263,0.0000724704,0.0001492565,0.00004375815,0.00007304139,0.000009000761,0.0001490657,0.000201916,0.00001270943],"category_scores_gemma":[0.0001279091,0.0000637819,0.00004304621,0.00008750273,0.0002702597,0.000001082225,0.00006593042,0.000107783,6.494777e-7],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0000972947,"about_ca_system_score_gemma":0.002114905,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_topic_score_codex":0.05066136,"about_ca_topic_score_gemma":0.7076133,"domain_scores_codex":[0.9992353,0.00006619721,0.0002415845,0.0002115632,0.00002567499,0.000219708],"domain_scores_gemma":[0.9994591,0.0001009455,0.00005156856,0.0001926848,0.00006284465,0.0001328669],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.00006714441,0.00003286126,0.7462606,0.000004998623,0.00004050285,0.000002608235,0.00001448187,0.000001961375,0.0005794827,0.0008504129,0.006021638,0.2461233],"study_design_scores_gemma":[0.0003678763,0.00007896254,0.5041639,0.00001172877,0.00001831743,0.000003389517,0.0001069278,0.00007666167,0.0008573508,0.0005125368,0.4937424,0.00005989639],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9728612,0.009798798,0.000003276703,0.007207276,0.0003622175,0.0002299432,0.0002016425,0.000002034722,0.009333585],"genre_scores_gemma":[0.9932445,0.005512047,0.00003091932,0.000956281,0.00007777438,0.00003653752,0.00001123972,0.000005108112,0.000125638],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.656952,"threshold_uncertainty_score":0.9556603,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4403604822","doi":"10.58931/cot.2024.1224","title":"An Evolving Paradigm in Borderline Resectable and Locally Advanced Pancreatic Cancer: Current Strategies and Opportunities for the Future","year":2024,"lang":"en","type":"article","venue":"Canadian oncology today.","topic":"Pancreatic and Hepatic Oncology Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Current (fluid); Medicine; Pancreatic cancer; Cancer; Intensive care medicine; Internal medicine; Engineering; Electrical engineering","authors":[{"name":"Arman Zereshkian","is_ca":true},{"name":"Erica S. Tsang","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.05318225327021265,"gpt":0.3834073223953514,"spread":0.3302250691251387,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000596714,0.0001672346,0.0004655351,0.0002685387,0.0002236961,0.0001030731,0.0001042456,0.0001861972,0.0001444709],"category_scores_gemma":[0.00008689699,0.0001203222,0.00002874788,0.0001586516,0.0003796928,0.0002589325,0.00001979565,0.0004278253,0.000001239365],"about_ca_system_candidate":true,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000550579,"about_ca_system_score_gemma":0.008306015,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_topic_score_codex":0.01832832,"about_ca_topic_score_gemma":0.4628008,"domain_scores_codex":[0.9986568,0.0001102314,0.0002496462,0.0003331312,0.0001026858,0.0005474873],"domain_scores_gemma":[0.9985064,0.0006620153,0.00003102812,0.0002095076,0.0000931337,0.0004978649],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0004666707,0.00008488357,0.05015236,0.001096149,0.0002571245,0.0009072051,0.00291014,0.0000378649,0.0001497006,0.03165767,0.01073374,0.9015465],"study_design_scores_gemma":[0.002986084,0.002313958,0.1154999,0.000937161,0.0004869174,0.0003072766,0.0218066,0.05900733,0.000007350494,0.004823419,0.7914844,0.0003395505],"study_design_candidate":"design_other","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.6087474,0.3224835,0.0003274531,0.06272156,0.000646522,0.001755988,0.0001172176,0.00005519442,0.003145237],"genre_scores_gemma":[0.9486976,0.04783458,0.0004362182,0.0009526036,0.0005330324,0.000669841,0.00004661846,0.00003046192,0.0007990605],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.9012069,"threshold_uncertainty_score":0.9973159,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4409361702","doi":"10.58931/cot.2025.2131","title":"Clinical Considerations for the Management of Advanced PD-L1 ≥50% Non-small Cell Lung Cancer In 2025: Should All Patients Be Treated the Same?","year":2025,"lang":"en","type":"article","venue":"Canadian oncology today.","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"Centre Hospitalier de l’Université de Montréal; Université de Montréal","funders":"","keywords":"Lung cancer; Medicine; Intensive care medicine; Cancer; Oncology; Internal medicine","authors":[{"name":"Lorena Alexandra Mija","is_ca":true},{"name":"Arielle Elkrief","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.04781192108716303,"gpt":0.3763830102409679,"spread":0.3285710891538048,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004266228,0.000141882,0.0003477594,0.0001338182,0.0001484896,0.000009231816,0.0001604415,0.0001922381,0.0003591391],"category_scores_gemma":[0.00005072786,0.00009404936,0.0001467525,0.0002314037,0.0002141993,0.00002222275,0.00002614417,0.0002302812,0.000001257094],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0007836101,"about_ca_system_score_gemma":0.001789647,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_topic_score_codex":0.03551166,"about_ca_topic_score_gemma":0.5729484,"domain_scores_codex":[0.9987037,0.00008992559,0.0005292363,0.0002601721,0.00007756055,0.00033939],"domain_scores_gemma":[0.998485,0.000802457,0.0001237346,0.0003551998,0.00012087,0.000112709],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.005267183,0.0009006627,0.3841574,0.0008055039,0.003378517,0.0001094418,0.002312095,0.0004186213,0.0004948693,0.001010826,0.3626089,0.238536],"study_design_scores_gemma":[0.01366257,0.0006563818,0.577341,0.0006538393,0.0009689108,0.000001857516,0.001337808,0.0006658908,0.0003649749,0.0001086654,0.4040394,0.0001987388],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.8238605,0.00946243,0.0001071857,0.1224509,0.002914155,0.0101052,0.0005808539,0.0000299643,0.03048885],"genre_scores_gemma":[0.9487644,0.003516635,0.0006296555,0.03778542,0.00007907786,0.00116471,0.00006164191,0.00002443394,0.007974054],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.5374367,"threshold_uncertainty_score":0.970911,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null}]}